Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul 7;6(8):888-93.
doi: 10.1021/acsmedchemlett.5b00138. eCollection 2015 Aug 13.

Discovery of Potent and Selective Inhibitors for ADAMTS-4 through DNA-Encoded Library Technology (ELT)

Affiliations

Discovery of Potent and Selective Inhibitors for ADAMTS-4 through DNA-Encoded Library Technology (ELT)

Yun Ding et al. ACS Med Chem Lett. .

Abstract

The aggrecan degrading metalloprotease ADAMTS-4 has been identified as a novel therapeutic target for osteoarthritis. Here, we use DNA-encoded Library Technology (ELT) to identify novel ADAMTS-4 inhibitors from a DNA-encoded triazine library by affinity selection. Structure-activity relationship studies based on the selection information led to the identification of potent and highly selective inhibitors. For example, 4-(((4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-6-(((4-methylpiperazin-1-yl)methyl)amino)-1,3,5-triazin-2-yl)amino)methyl)-N-ethyl-N-(m-tolyl)benzamide has IC50 of 10 nM against ADAMTS-4, with >1000-fold selectivity over ADAMT-5, MMP-13, TACE, and ADAMTS-13. These inhibitors have no obvious zinc ligand functionality.

Keywords: ADAMTS-4; DNA-encoded library; inhibitors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Selection of library against ADAMTS-4. (a) The triazine library. (b) The cube corresponding to 4-(aminomethyl)benzoic acid as cycle 2 is shown in detail. The copy number of the selected species is indicated by the continuous color and size of the points (darker and bigger points indicate higher copy number). The structure shown at the bottom represents the family of compounds defined by a line along the BB1 axis (arrow).
Scheme 1
Scheme 1. Synthesis of ADAMTS-4 Off-DNA Hits
Reagents and conditions: (i) amine (1 equiv), EDCI (1.25 equiv), DMAP (0.2 equiv), CH2Cl2, 0 °C – rt; (ii) TFA (50% in CH2Cl2), room temperature, 20 min; (iii) amine (1 equiv), CH3CN/H2O (1/1), pH 9–10, 0 °C; (iv) amine (R2NH2 or R3) (1 equiv), CH3CN/H2O (1/1), pH 9–10, room temperature overnight; (v) R3 = H: Pd/C, H2, room temperature 1 h; R3 = OH/HCl (6 N, 10% v/v), CH3CN/H2O (1/1), 80 °C overnight; R3 = amines/amine (5–10 equiv), CH3CN/H2O (1/1), 80 °C; (vi) amine (1 equiv), DIEA (2.5 equiv), NMP, 0 °C; (vii) amine (5 equiv), NMP, 80 °C for 1 h; (viii) 1 N NaOH, room temperature overnight.

References

    1. Tortorella M. D.; Malfait A. M. Will the Real Aggrecanase(s) Step Up: Evaluating the Criteria That Define Aggrecanase Activity in Osteoarthritis. Curr. Pharm. Biotechnol. 2008, 9, 16–23. 10.2174/138920108783497622#sthash.Wj45IQRp.dpuf. - DOI - PubMed
    1. Rienzo F. D.; Saxena P.; Filomia F.; Caselli C.; Colace F.; Stasi L.; Giordani A.; Menziani M. C. Progress Towards the Identification of New Aggrecanase Inhibitors. Curr. Med. Chem. 2009, 16, 2395–2415. 10.2174/092986709788682092. - DOI - PubMed
    1. Malfait A. M.; Liu R. Q.; Ijiri K.; Setsuro K.; Tortorella M. Inhibition of ADAM-TS4 and ADAM-TS5 Prevents Aggrecan Degradation in Osteoarthritic Cartilage. J. Biol. Chem. 2002, 277, 22201–22208. 10.1074/jbc.M200431200. - DOI - PubMed
    1. Fajardo M.; Di Cesare P. E. Disease-Modifying Therapies for Osteoarthritis: Current Status. Drugs Aging 2005, 22, 141–164. 10.2165/00002512-200522020-00005. - DOI - PubMed
    1. Porter S.; Clark I. M.; Kevorkian L.; Edwards D. R. The ADAMTS Metalloproteinases. Biochem. J. 2005, 386, 15–27. 10.1042/BJ20040424. - DOI - PMC - PubMed